<DOC>
	<DOCNO>NCT00841256</DOCNO>
	<brief_summary>Evaluation safety efficacy sublingual immunotherapy grass pollen allergen formulate solution comparison symptomatic standard treatment add placebo grass pollen allergic child suffer allergic rhinitis/rhinoconjunctivitis without bronchial asthma .</brief_summary>
	<brief_title>Multicenter Trial Sublingual Immunotherapy With Solution Grass Pollen Allergen Extract Children</brief_title>
	<detailed_description>Although highly effective , subcutaneous administration allergen may cause inconvenience patient . Alternative route , e.g . nasal oral , therefore investigated find immunotherapy regimen largely accept group patient , include child . Sublingual specific immunotherapy ( SLIT ) may represent acceptable route immunotherapy . It may optimal therapy option especially child often fear injection . In study child treat preparation grass pollen allergen extract water/glycerol solution phosphate buffer saline comparison symptomatic standard treatment add placebo , order investigate efficacy safety study drug .</detailed_description>
	<mesh_term>Conjunctivitis , Allergic</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Glycerol</mesh_term>
	<criteria>4 &lt; 12 year ( time inclusion ) Positive SPT Positive EAST Positive CPT Serious chronic diseases Other perennial allergy</criteria>
	<gender>All</gender>
	<minimum_age>4 Years</minimum_age>
	<maximum_age>11 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>specific immunotherapy</keyword>
	<keyword>SIT</keyword>
	<keyword>SLIT</keyword>
	<keyword>sublingual</keyword>
</DOC>